▲ Peaking
Business
Novo's CEO Called Ozempic's Patent Cliff the "Elephant in the Room" Yesterday. Is the Stock Still a Buy?
0sources
0articles
0velocity
3h agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (0)
Related trends
▲ Peaking
Business
Cybercriminal group claims to steal thousands of FBI employee records
▲ Peaking
Business
Trump says he backs diesel export ban to curb soaring energy costs
▲ Peaking
Business
Hundreds of lawsuits allege GLP-1s like Ozempic, Wegovy, Mounjaro caused vision loss
▲ Peaking
Business
N.J.’s largest AI data center hit with a stunning $1M fine for pollution
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
▲ Peaking
Business
Massachusetts lesbian bar nearly bullied out of town after lifting mask mandate
▲ Peaking
Business
A Western Mass. lesbian bar required KN-95 masks. When it changed the rules, all hell broke loose.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.